%20--%3e%3csvg%20width='63.297821mm'%20height='39.29665mm'%20viewBox='0%200%2063.297821%2039.29665'%20version='1.1'%20id='svg8765'%20inkscape:version='1.1%20(c4e8f9ed74,%202021-05-24)'%20sodipodi:docname='OBALogoSingle2.svg'%20xmlns:inkscape='http://www.inkscape.org/namespaces/inkscape'%20xmlns:sodipodi='http://sodipodi.sourceforge.net/DTD/sodipodi-0.dtd'%20xmlns='http://www.w3.org/2000/svg'%20xmlns:svg='http://www.w3.org/2000/svg'%3e%3csodipodi:namedview%20id='namedview8767'%20pagecolor='%23ffffff'%20bordercolor='%23666666'%20borderopacity='1.0'%20inkscape:pageshadow='2'%20inkscape:pageopacity='0.0'%20inkscape:pagecheckerboard='0'%20inkscape:document-units='mm'%20showgrid='false'%20fit-margin-top='0'%20fit-margin-left='0'%20fit-margin-right='0'%20fit-margin-bottom='0'%20inkscape:zoom='1.1759259'%20inkscape:cx='179.85827'%20inkscape:cy='102.04724'%20inkscape:window-width='1920'%20inkscape:window-height='972'%20inkscape:window-x='0'%20inkscape:window-y='27'%20inkscape:window-maximized='1'%20inkscape:current-layer='layer1'%20/%3e%3cdefs%20id='defs8762'%20/%3e%3cg%20inkscape:label='Layer%201'%20inkscape:groupmode='layer'%20id='layer1'%20transform='translate(-31.351095,-50.101677)'%3e%3cpath%20style='fill:none;stroke:%233584e4;stroke-width:3.965;stroke-linecap:square;stroke-linejoin:round;stroke-miterlimit:4;stroke-dasharray:none;stroke-opacity:1'%20d='m%2077.07508,77.78787%2014.84134,8.87817%20V%2052.83397%20L%2034.08359,86.5521%20V%2053.69366%20l%2015.27351,9.31107'%20id='path8388'%20sodipodi:nodetypes='cccccc'%20/%3e%3c/g%3e%3c/svg%3e)
Market Performance
Stock returned +10.0% over the past year, broadly in line with market conditions.What is Holdco Nuvo Group D.G Ltd?
G Ltd engages in the research and development of medical devices for pregnancy monitoring in Israel, the United States, and internationally.
NUVOQ · Verdict
Limited reward · high risk
NUVOQ has limited near-term tailwinds — volatility and cash flow weigh on the model output.
Based on 88% data coverage
NUVOQ · Verdict
What’s working & what to watch
Watchouts 5
- Volatility5/100
Weak vs peers
- Cash flow7/100
-8519% free-cash-flow margin
- Profitability9/100
-19122% net margin · 0% ROE
- Balance sheet14/100
Current ratio 0.05
- Growth18/100
Earnings -1.2% CAGR
Model-based scoring. For information only — not financial advice.
What is Holdco Nuvo Group D.G Ltd?
G Ltd engages in the research and development of medical devices for pregnancy monitoring in Israel, the United States, and internationally. The company provides the INVU platform, a remote pregnancy monitoring system that offers mothers and doctors the information needed to complete fetal monitoring remotely. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 3.33K.
Financial Highlights
Investment Breakdown
Analysis
Reward: Low (30)The scoring profile indicates weak reward characteristics across most factors, including valuation and momentum. Risk indicators are high — this profile reflects meaningful downside exposure.
For informational purposes only. Not financial advice.